Acute Myelogenous Leukemia, Adult
1 clinical trials · Condition
◉ Watch Acute Myelogenous Leukemia, Adult
| Record | Firm | Date |
|---|---|---|
| A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS (NCT02267863) | Aptose Biosciences Inc. | 2014-10-01 |
Track Acute Myelogenous Leukemia, Adult automatically
Every clearance here is in the API, with alerts when new ones post.